Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells

Hong Xin, Masahiko Kanehira, Hiroyuki Mizuguchi, Takao Hayakawa, Toshiaki Kikuchi, Toshihiro Nukiwa, Yasuo Saijo

Research output: Contribution to journalArticlepeer-review

149 Citations (Scopus)


MSCs are nonhematopoietic stem cells capable of differentiating into various mesoderm-type cells. MSCs have been considered to be a potential vehicle for cell-based gene therapy because MSCs are relatively easily expanded in vitro and have the propensity to migrate to and proliferate in the tumor tissue after systemic administration. Here, we demonstrated the tropism of mouse MSCs to tumor cells in vitro and multiple tumor tissues in the lung after i.v. injection of green fluorescent protein-positive MSCs in vivo. We transduced CX3CL1 (fractalkine), an immunostimulatory chemokine, to the mouse MSCs ex vivo using an adenoviral vector with the Arg-Gly-Asp-4C peptide in the fiber knob. Intravenous injection of CX3CL1-expressing MSCs to the mice bearing lung metastases of C26 and B16F10 cells strongly inhibited the development of lung metastases and thus prolonged the survival of these tumor-bearing mice. This antitumor effect depended on both innate and adaptive immunity. These results suggest that MSCs can be used as a vehicle for introducing biological agents into multiple lung tumor tissues.

Original languageEnglish
Pages (from-to)1618-1626
Number of pages9
JournalStem Cells
Issue number7
Publication statusPublished - 2007 Jul
Externally publishedYes


  • Gene therapy
  • Lung metastases
  • Mesenchymal stem cell
  • Multiple tumors

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology


Dive into the research topics of 'Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells'. Together they form a unique fingerprint.

Cite this